157 related articles for article (PubMed ID: 31966520)
1. Correlation of HER2 and FOXM1 in human colorectal carcinoma and its clinical significance.
Lu M; Hu K
Int J Clin Exp Pathol; 2017; 10(12):11624-11634. PubMed ID: 31966520
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1.
Xu K; Liu X; Mao X; Xue L; Wang R; Chen L; Chu X
Cell Physiol Biochem; 2015; 35(2):499-515. PubMed ID: 25613903
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer.
Rather TB; Parveiz I; Bhat GA; Rashid G; Wani RA; Khan IY; Mudassar S
Clin Exp Med; 2023 Oct; 23(6):2385-2405. PubMed ID: 36318377
[TBL] [Abstract][Full Text] [Related]
5. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
6. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
7. FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition.
Fei BY; He X; Ma J; Zhang M; Chai R
Oncol Lett; 2017 Dec; 14(6):6553-6561. PubMed ID: 29163688
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis.
Yao Y; Wang X; Jiang L; Shao X; Zhu X; He S
Medicine (Baltimore); 2018 Dec; 97(52):e13899. PubMed ID: 30593202
[TBL] [Abstract][Full Text] [Related]
9. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
[TBL] [Abstract][Full Text] [Related]
10. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
Kuai XY; Lei ZY; Liu XS; Shao XY
Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer.
Li X; Tang D; Yao Y; Qi W; Liang J
Clin Exp Med; 2014 Nov; 14(4):447-55. PubMed ID: 24101296
[TBL] [Abstract][Full Text] [Related]
15. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
16. Expression and potential correlation among Forkhead box protein M1, Caveolin-1 and E-cadherin in colorectal cancer.
Zhang J; Zhang K; Zhou L; Wu W; Jiang T; Cao J; Huang K; Qiu Z; Huang C
Oncol Lett; 2016 Oct; 12(4):2381-2388. PubMed ID: 27698803
[TBL] [Abstract][Full Text] [Related]
17. [Expression of FoxM1 and BCRP in invasive breast carcinoma of no special type and its prognosis significance].
Liu Y; Liu YP; Liu JY; Yang HC; Wang ZD
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):30-33. PubMed ID: 28072973
[No Abstract] [Full Text] [Related]
18. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 promotes the growth and metastasis of colorectal cancer via activation of β-catenin signaling pathway.
Yang K; Jiang B; Lu Y; Shu Q; Zhai P; Zhi Q; Li Q
Cancer Manag Res; 2019; 11():3779-3790. PubMed ID: 31118796
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.
Ma J; Qi G; Xu J; Ni H; Xu W; Ru G; Zhao Z; Xu W; He X
Oncol Lett; 2017 Dec; 14(6):7288-7296. PubMed ID: 29344165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
